Petros Pharmaceuticals, Inc. (PTPI)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Petros Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Petros Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

1

Exchange

Nasdaq

$6M

Total Revenue

1

Employees

$2M

Market Capitalization

-0.08

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PTPI News

Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health

2d ago, source:

Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED ...

Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health

22h ago, source:

Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, ...

PTPI Petros Pharmaceuticals, Inc.

20d ago, source: Seeking Alpha

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men’s health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications ...

Petros Pharmaceuticals Inc Ordinary Shares

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Petros Pharma Stock Down, Despite Positive Results For Stendra Study

24d ago, source: Business Insider

(RTTNews) - Petros Pharmaceuticals, Inc. (PTPI) shares are declining more than 21 percent on Tuesday morning trade, continuing a bearish trend since last week. Petros Pharma reported positive ...

Positive Outlook for Petros Pharmaceuticals: Buy Rating Affirmed Amidst FDA Advances and Promising Stendra Developments

8d ago, source:

In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Petros Pharmaceuticals (PTPI – Research Report), ...

Petros Pharmaceuticals partners with Lemonaid Health for ED drug distribution

3d ago, source: Investing

NEW YORK - Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a firm dedicated to improving consumer access to over-the-counter (OTC) medications, has announced a collaboration with Lemonaid Health ...

Petros Pharmaceuticals Inc (PTPI)

10d ago, source: Investing

At the close... Petros Pharmaceuticals, Inc. (PTPI) announces a new partnership with a leading, multi-billion-dollar AI software provider to adapt its technology for self-screening and other ...

Petros Pharmaceuticals, Inc.: Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health

2d ago, source:

Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients(Please see important safety information below)NEW YORK, NY / ACCESSWIR ...

Petros Pharmaceuticals Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Petros Pharmaceuticals Inc Ordinary Shares PTPI

1mon ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...